In-vitro Fertilization (IVF) Market Analysis

  • Report ID: 6483
  • Published Date: Sep 18, 2025
  • Report Format: PDF, PPT

In-vitro Fertilization Market Segmentation:

Product Segment Analysis

The equipment segment in the in-vitro fertilization market is projected to hold a revenue share of 44.8% by the end of 2035. The growth is attributed to increased demand for advanced medical devices and laboratory instruments essential for successful fertility treatments. The need for precise, efficient, and safe handling of gametes and embryos, and improved success rates of IVF are also driving the segment’s growth significantly. Companies in partnership with other institutions are also focusing on developing a wide array of equipment to meet this rising demand.

For instance, in May 2022, a research team from the University of Adelaide announced the development of a ground-breaking new micro-device, in partnership with medical technology company Fertilis.  This micro-device was introduced to streamline the only fertility treatment procedure available for men with low sperm counts Additionally, increasing infertility rates have given rise to multiple fertility clinics all around the world. This in turn has further bolstered the demand for IVF equipment, making it the leading segment under products.

End use Segment Analysis

Fertility clinics and IVF centers dominated the end use segment as these specialized centers offer comprehensive services, including advanced diagnostic tools, personalized treatment plans, and cutting-edge IVF procedures. Moreover, the expansion of fertility clinics, in both developed and developing regions has made IVF treatments more accessible. For instance, in June 2024, Kindbody, a leading fertility clinic network in the U.S., announced the opening of a state-of-the-art clinic in Newport Beach, CA. The company will add an in vitro fertilization (IVF) lab to meet the growing demand for comprehensive fertility in the area.

The rising demand for higher success rates and expert care provided by these clinics has positioned them as the leading end use segment in the IVF market. Clinics and IVF centers usually offer a better patient-centric environment, offering streamlined processes and shorter waiting times. This enhances the overall patient experience in comparison to larger hospitals, making the clinics a better choice. As per an article by The Economic Times, September 2024, India is home to over 2,500 fertility clinics at present.

Our in-depth analysis of the in-vitro fertilization market includes the following segments:

          Product

  • Equipment
  • Reagents & media
  • Accessories

          Type of Cycle

  • Fresh non-donors
  • Frozen non-donors
  • Frozen donors
  • Fresh donors

          Procedure

  • Conventional IVF
  • IVF with intracytoplasmic sperm injections
  • Minimal IVF
  • IVF with donor eggs
  • Other procedures

          End use

  • Fertility clinics and IVF centers
  • Hospitals & surgical centers
  • Research institutes
  • Cryobanks

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of in-vitro fertilization is assessed at USD 28.64 billion.

The global in-vitro fertilization market size surpassed USD 27.06 billion in 2025 and is projected to grow at a CAGR of more than 6.5%, reaching USD 50.8 billion revenue by 2035.

North America in-vitro fertilization (IVF) market will account for 30.50% share by 2035, driven by developed healthcare infrastructure, IVF technology advancements, and a well-regulated medical industry.

Key players in the market include CooperSurgical, Inc., Vitrolife AB, Cook Medical, Inc., Merck KGaA, Ferring Pharmaceuticals, Irvine Scientific (FUJIFILM), Thermo Fisher Scientific Inc., Genea Biomedx, OvaScience, Inc., Progyny, Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos